India Glaucoma Outcomes and Treatment Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN52778666

Enrollment

700

Registered

2006-03-30

Start date

2003-01-01

Completion date

Unknown

Last updated

2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Eye Diseases Glaucoma

Interventions

Medicine (timolol, latanaprost and brimonidine) versus surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Glaucoma patients over the age of 30 years in India

Exclusion criteria

Exclusion criteria: 1. Previous surgery 2. Intraocular pressure (IOP) >35

Design outcomes

Primary

Measure	Time frame
1. Intraocular pressure 2. Visual acuity 3. Quality of life	—

Secondary

Measure	Time frame
Cataract grade	—

Countries

India

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026